Thomas Blevins
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Thyroid Cancer Diagnosis and Treatment
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Pharmacology top 2%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Management and Research 42
- Diabetes Treatment and Management 25
- Thyroid Cancer Diagnosis and Treatment 4
- Growth Hormone and Insulin-like Growth Factors 1
-
- Biosimilars and Bioanalytical Methods 7
- Co-authors
- George Grunberger (4 shared papers)Julio Rosenstock (8 shared papers)Jaret L. Malloy (1 shared paper)Christine T. Schulteis (1 shared paper)MICHAEL E. TRAUTMANN (1 shared paper)Kristin Taylor (1 shared paper)Ping Yan (1 shared paper)John R. Pullman (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (11 papers)Diabetes Care (10 papers)Diabetes Technology & Therapeutics (7 papers)Endocrine Practice (6 papers)The Lancet (3 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Thomas Blevins
70 papers receiving 4k citations
Thomas Blevins's Hit Papers
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 3.3k
- Pharmacology 495
- Endocrine and Autonomic Systems 67
- Immunology 143
- Pharmacy 25
Countries citing papers authored by Thomas Blevins
This map shows the geographic impact of Thomas Blevins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Blevins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Blevins more than expected).
Fields of papers citing papers by Thomas Blevins
This network shows the impact of papers produced by Thomas Blevins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Blevins. The network helps show where Thomas Blevins may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Blevins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Hit paper breakdown → | 2017 | 657 |
| 2 | DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes Hit paper breakdown → | 2011 | 387 |
| 3 | Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Hit paper breakdown → | 2023 | 343 |
| 4 | 2014 | 339 | |
| 5 | Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules Hit paper breakdown → | 2018 | 297 |
| 6 | 2014 | 216 | |
| 7 | American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus Hit paper breakdown → | 2021 | 208 |
| 8 | A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings Hit paper breakdown → | 2022 | 199 |
| 9 | 2016 | 155 | |
| 10 | 2016 | 129 | |
| 11 | 2014 | 111 | |
| 12 | 2012 | 88 | |
| 13 | 2018 | 85 | |
| 14 | 2011 | 75 | |
| 15 | 2018 | 72 | |
| 16 | 2010 | 70 | |
| 17 | 2015 | 64 | |
| 18 | 2020 | 55 | |
| 19 | A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes Hit paper breakdown → | 2025 | 47 |
| 20 | 2016 | 42 |
About Thomas Blevins
Thomas Blevins is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology, Pharmacology, Clinical Biochemistry and Orthopedics and Sports Medicine, having authored 75 papers that have together received 4.3k indexed citations. Recurring topics across this work include Diabetes Management and Research (42 papers), Diabetes Treatment and Management (25 papers), Biosimilars and Bioanalytical Methods (7 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Pharmacology and Obesity Treatment (3 papers), Growth Hormone and Insulin-like Growth Factors (1 paper), Bone health and osteoporosis research (1 paper) and Telemedicine and Telehealth Implementation (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.3k citations), Pharmacology (495 citations), Endocrine and Autonomic Systems (67 citations), Immunology (143 citations) and Pharmacy (25 citations). Thomas Blevins has collaborated with scholars based in United States, Canada and India. Frequent co-authors include George Grunberger, Julio Rosenstock, Jaret L. Malloy, Christine T. Schulteis, MICHAEL E. TRAUTMANN, Kristin Taylor, Ping Yan, John R. Pullman, Carol Wysham and Richard F. Arakaki. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes Care, Diabetes Technology & Therapeutics, Endocrine Practice and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.